CARBOPLATIN , PEMETREXED , CISPLATIN , Abraxane 5 mg/ml powder for dispersion for infusion., PEMBROLIZUMAB, PACLITAXEL clinical trials

A Biomarker-Directed, Multi-Centre Phase II/III Study of ctDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer - BR.36

This study looks at new ways to treat advanced lung cancer using medicine and the body's own defense system. Researchers are testing if checking your blood for cancer DNA can help choose the best treatment to stop the cancer from growing.